Cite
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020.
MLA
Liu, Yuzhi, et al. “The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020.” European Journal of Medicinal Chemistry, vol. 206, Nov. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ejmech.2020.112711.
APA
Liu, Y., Liang, C., Xin, L., Ren, X., Tian, L., Ju, X., Li, H., Wang, Y., Zhao, Q., Liu, H., Cao, W., Xie, X., Zhang, D., Wang, Y., & Jian, Y. (2020). The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020. European Journal of Medicinal Chemistry, 206, N.PAG. https://doi.org/10.1016/j.ejmech.2020.112711
Chicago
Liu, Yuzhi, Chengyuan Liang, Liang Xin, Xiaodong Ren, Lei Tian, Xingke Ju, Han Li, et al. 2020. “The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020.” European Journal of Medicinal Chemistry 206 (November): N.PAG. doi:10.1016/j.ejmech.2020.112711.